IMN || Oncology

Erectile dysfunction meds’ link to melanoma not causal

Posted on: 27/06/2015 - 15:19

The erectile dysfunction agents sildenafil, vardenafil, and tadalafil showed a modest but significant association with increased risk of malignant melanoma in a large Swedish cohort study, but the...

Field of Interest: Oncology
Type: News Item

Advanced age no barrier to continuous myeloma regimen

Posted on: 26/06/2015 - 13:08

VIENNA – Elderly patients over age 75 with newly diagnosed multiple myeloma derive the same survival benefits from continuous lenalidomide and low-dose dexamethasone as those under 75, according to a...

Field of Interest: Oncology
Type: News Item

Urine assay ruled out high-grade prostate cancer

Posted on: 21/06/2015 - 19:14

NEW ORLEANS – A urine assay test can provide a high negative predictive value to rule out the presence of high-grade, clinically significant prostate cancer without the need for a digital rectal exam...

Field of Interest: Oncology
Type: News Item

Prostate cancer screening for men over 50 has declined

Posted on: 08/06/2015 - 21:00

Subsequent to the 2012 U.S. Preventative Services Task Force recommendation discouraging prostate-specific antigen (PSA)-based screening, prostate cancer screening significantly declined among men...

Field of Interest: Oncology
Type: News Item

Research IDs new subtype of refractory prostate cancer

Posted on: 04/06/2015 - 22:45

CHICAGO – Researchers have identified a new histologic subset of metastatic castration-resistant prostate cancer called intermediate atypical carcinoma. “Despite being cytologically bland, this is...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness